Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureYosuke Fukuda, Yoshihisa Miyamoto, Norio Watanabe
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Japanese guidelines for adult asthma 2020
10.1016/j.alit.2020.08.001 · 2020
The link between fungi and severe asthma: a summary of the evidence
10.1183/09031936.06.00074705 · 2006
New perspectives in the diagnosis and management of allergic fungal airway disease
10.2147/jaa.s251709 · 2021
Sensitization to fungal allergens: resolved and unresolved issues
10.1016/j.alit.2015.05.007 · 2015
Severe asthma with fungal sensitization
10.1007/s11882-011-0217-4 · 2011
Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses
10.1183/13993003.00061-2024 · 2024
Unresolved referenced work
2025
A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
10.1016/j.chest.2018.01.005 · 2018
Allergic fungal airway disease: pathophysiologic and diagnostic considerations
10.1097/mcp.0000000000000129 · 2015
Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study)
10.1016/j.jaci.2013.09.050 · 2014
Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) study
10.1164/ajrccm.179.4.330b · 2009
Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial
10.1067/mai.2003.1388 · 2003
Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
10.1002/14651858.cd002204.pub4 · 2016
Nebulized amphotericin B for preventing exacerbations in allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis
10.1016/j.pupt.2023.102226 · 2023
Azoles for allergic bronchopulmonary aspergillosis associated with asthma
10.1002/14651858.cd001108.pub2 · 2004
Unresolved referenced work
Kept as external metadata until matched
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1136/bmj.n71 · 2021
GRADE Guidance 44: strategies to enhance the utilization of randomized and non-randomized studies in evidence syntheses of health interventions
10.1016/j.jclinepi.2025.112086 · 2026
Unresolved referenced work
Kept as external metadata until matched
New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation
10.1016/j.jaci.2020.08.029 · 2021
Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma
10.1016/0091-6749(88)91034-2 · 1988
Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis
10.7326/0003-4819-86-4-405 · 1977
Validation of a standardized version of the Asthma Quality of Life Questionnaire
10.1378/chest.115.5.1265 · 1999
Development of the asthma control test: a survey for assessing asthma control
10.1016/j.jaci.2003.09.008 · 2004
Development and validation of a questionnaire to measure asthma control
10.1034/j.1399-3003.1999.14d29.x · 1999
The St George's respiratory questionnaire
10.1016/s0954-6111(06)80166-6 · 1991
Core GRADE 7: principles for moving from evidence to recommendations and decisions
10.1136/bmj-2024-083867 · 2025
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Rayyan − a web and mobile app for systematic reviews
10.1186/s13643-016-0384-4 · 2016
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
10.1002/9781119536604.ch9
10.1002/9781119536604.ch9
Unresolved referenced work
Kept as external metadata until matched
10.1002/9781119536604.ch8
10.1002/9781119536604.ch8
10.1002/9781119536604.ch25
10.1002/9781119536604.ch25
Unresolved referenced work
Kept as external metadata until matched
GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence
10.1016/j.jclinepi.2017.05.005 · 2017
10.1002/9781119536604.ch12
10.1002/9781119536604.ch12 · doi-reference
